| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$26,011,738 |
|
|
|
Indirect Value
|
$90,745,486 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$116,757,223 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2009-02-03 |
4 |
OE |
$6.43 |
$109,310 |
D/D |
17,000 |
56,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2009-03-02 |
4 |
OE |
$6.43 |
$50,778 |
D/D |
7,897 |
47,518 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-03-12 |
4 |
OE |
$3.01 |
$449,998 |
D/D |
149,700 |
654,500 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2023-10-19 |
4 |
OE |
$6.86 |
$328,272 |
D/D |
47,853 |
647,029 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-11-25 |
4 |
S |
$15.98 |
$1,198,740 |
D/D |
(75,000) |
39,621 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-03-05 |
4/A |
S |
$65.52 |
$189,353 |
D/D |
(2,890) |
467,583 |
0 |
- |
|
106 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
